28May/13

Organ donor rule leaves dying 10-year-old waiting for lung transplant behind … – New York Post


New York Post

Organ donor rule leaves dying 10-year-old waiting for lung transplant behind
New York Post
The parents of a 10-year-old girl dying of cystic fibrosis are fighting organ-donation rules that require adult lungs be offered first to adults, who are in less serious need than their daughter. Sarah Murnaghan, who has only weeks to live, is eligible
Organ Donor Law May Keep Sarah Murnaghan From Getting The Life-Saving Medical Daily
Dying 10-Year-Old Can’t Get Life-Saving Lung Transplant Because She’s Just a The Stir
Dying 10-Year-Old in Need of Lung Transplant, Must Wait Until Organs Are Opposing Views
msnNOW –Parent Herald –Philly.com
all 19 news articles »
28May/13

Immunomedics Invents Method to Label Peptides and Other Proteins, Including … – Yahoo! New Zealand News

Immunomedics Invents Method to Label Peptides and Other Proteins, Including
Yahoo! New Zealand News
We have developed a number of advanced proprietary technologies that allow us to create humanized antibodies that can be used either alone in unlabeled or “naked” form, or conjugated with radioactive isotopes, chemotherapeutics, cytokines or toxins,

28May/13

Life Technologies Announces Regulatory Approval of Its 3500 Dx Series Genetic … – ThomasNet Industrial News Room (press release)

Life Technologies Announces Regulatory Approval of Its 3500 Dx Series Genetic
ThomasNet Industrial News Room (press release)
In February 2013, the 3500 Dx/3500xL Dx Genetic Analyzers CS2 Series received U.S. Food and Drug Administration (FDA) 510(k) clearance for use with the company’s SeCore® HLA typing kits. Additional products offered by Life Technologies for the

and more »

28May/13

Immunomedics Invents Method to Label Peptides and Other Proteins, Including … – MarketWatch (press release)

Immunomedics Invents Method to Label Peptides and Other Proteins, Including
MarketWatch (press release)
We have developed a number of advanced proprietary technologies that allow us to create humanized antibodies that can be used either alone in unlabeled or “naked” form, or conjugated with radioactive isotopes, chemotherapeutics, cytokines or toxins,

and more »